TITLE

Nicotine Replacement Therapy and Cardiovascular Disease

AUTHOR(S)
Ford, Catherine L.; Zlabek, Jonathan A.
PUB. DATE
May 2005
SOURCE
Mayo Clinic Proceedings;May2005, Vol. 80 Issue 5, p652
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Smoking is a well-established and important risk factor for cardiovascular disease. Cessation of smoking clearly decreases the chances of a first or subsequent cardiovascular event. Nicotine replacement therapy (NRT) is a proven adjunctive therapy to increase the probability of quitting smoking. Anecdotal reports of adverse events in patients using NRT have led some to question its safety. Is nicotine, whether in tobacco products or in NRT, the cause of the cardiovascular consequences associated with tobacco use? is using NRT to assist with smoking cessation safer than smoking? Should health care professionals avoid recommending NRT for patients with established cardiovascular disease? This article summarizes the mechanisms of harm associated with smoking and reviews the safety of NRT in both the general population and the population with cardiovascular disease, Recommendations for NRT use are offered.
ACCESSION #
17019251

 

Related Articles

  • Disseminating a smoking cessation intervention to childhood and young adult cancer survivors: baseline characteristics and study design of the partnership for health-2 study. de Moor, Janet S.; Puleo, Elaine; Ford, Jennifer S.; Greenberg, Mark; Hodgson, David C.; Tyc, Vida L.; Ostroff, Jamie; Diller, Lisa R.; Levy, Andrea Gurmankin; Sprunck-Harrild, Kim; Emmons, Karen M. // BMC Cancer;2011, Vol. 11 Issue 1, p165 

    Background: Partnership for Health-2 (PFH-2) is a web-based version of Partnership for Health, an evidence-based smoking cessation intervention for childhood cancer survivors. This paper describes the PFH-2 intervention and baseline data collection. Methods: 374 childhood and young adult cancer...

  • Adherence to Nicotine Replacement Patch Therapy in Cardiovascular Patients. Wiggers, Louise C. W.; Smets, Ellen M. A.; Oort, Frans J.; Storm-Versloot, Marja N.; Vermeulen, Hester; van Loenen, Lucas B. M.; Peters, Ron J. G.; de Haes, Hanneke C. J. M.; Legemate, Dink A. // International Journal of Behavioral Medicine;Mar2006, Vol. 13 Issue 1, p79 

    Nicotine Replacement Therapy (NRT) is the most frequently used pharmacological intervention for smoking cessation. Research on the effect of NRT showed serious nonadherence among users. We investigated adherence to NRT in cardiovascular patients. A number of 174 outpatients (N = 174), who smoked...

  • Counseling is a must with this smoking cessation aid. Stephens, Luke A.; Stevermer, James J. // Journal of Family Practice;Mar2012, Vol. 61 Issue 3, p156 

    The article offers information on smoking cessation and the small cardiovascular (CV) associated with taking varenicline (Chantix). It mentions that nicotine replacement therapy (NRT), varenicline, and bupropion were identified the U.S. Preventive Services Task Force as effective smoking...

  • Effectiveness of Nicotine Inhaler for Smoking Cessation in an OTC Setting. Leischow, Scott J.; Ranger-Moore, James; Muramoto, Myra L.; Matthews, Eva // American Journal of Health Behavior;Jul/Aug2004, Vol. 28 Issue 4, p291 

    Objective: To evaluate the effectiveness of the Nicotrol® nicotine inhaler as an aid to smoking cessation in over-the-counter (OTC) versus health-care-provider (HCP) conditions. Methods: Five hundred twenty healthy smokers were randomized to the treatment conditions and followed for a year....

  • Adherence to nicotine replacement therapy versus quitting smoking among Chinese smokers: a preliminary investigation. Lam, Tai-Hing; Abdullah, Abu Saleh M.; Chan, Sophia S. C.; Hedley, Anthony J. // Psychopharmacology;Feb2005, Vol. 177 Issue 4, p400 

    Rationale: There are over 300 million Chinese smokers, but use of nicotine replacement therapy (NRT) is rare. On the other hand, data on the factors associated with quitting and adherence to NRT use are scarce in the East. Objectives: To describe adherence and other predictors of quitting...

  • Support for spirituality in smoking cessation: Results of pilot survey. Gonzales, David; Redtomahawk, Donovan; Pizacani, Barbara; Bjornson, Wendy G.; Spradley, Janet; Allen, Elizabeth; Lees, Paul // Nicotine & Tobacco Research;Feb2007, Vol. 9 Issue 2, p299 

    Patient spiritual resources are increasingly included in the treatment of medical conditions such as cancers and alcohol and drug dependence, but use of spiritual resources is usually excluded from tobacco dependence treatment. We hypothesized that this omission may be linked to perceived...

  • Research news. Drennan, Vari // Primary Health Care;Nov2014, Vol. 24 Issue 9, p17 

    The article presents abstracts on medical topics including the efficacy of handouts on uptake of contraception, comparison of tools to predict individual risk of heart disease, and the assessment of using varenicline therapy for smoking cessation.

  • Preventive Health Care in the elderly Population: A Guide for Practicing Physicians. Takahashi, Paul Y.; Okhravi, Hamid R.; Lim, Lionel S.; Kasten, Marry J. // Mayo Clinic Proceedings;Mar2004, Vol. 79 Issue 3, p416 

    Preventive medicine provides important benefits to all persons, including older adults; however, these benefits may be seen more clearly in younger adults than in older persons. Smoking cessation, proper nutrition, exercise, and immunizations are important regardless of age. The prevalence of...

  • Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting. Pacheco Silva, André; Scholz, Jaqueline; Abe, Tania Ogawa; Pinheiro, Gabriela Gouveia; Gaya, Patricia Viviane; Costa Pereira, Alexandre; Caleb Junior Lima Santos, Paulo; Silva, André Pacheco; Pereira, Alexandre Costa; Santos, Paulo Caleb Junior Lima // BMC Cardiovascular Disorders;1/5/2016, Vol. 16, p1 

    Background: Smoking is the most important reversible cardiovascular risk factor. It is well established that quitting smoking reduces coronary events. However, on several occasions, the cardiovascular safety of smoking cessation drugs has been questioned. Our goal is to evaluate the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics